Orphan Technologies

Lexington, United States Founded: 2010 • Age: 16 yrs Acquired By Retrophin
Enzyme replacement therapy for homocystinuria is being developed.

About Orphan Technologies

Orphan Technologies is a Healthcare company based in Lexington (United States) founded in 2010, and was acquired by Retrophin in October 2020. Enzyme replacement therapy for homocystinuria is being developed. Its focus areas include Life Sciences, Rare Diseases, Drugs and Diversified. Its competitors include BridgeBio, Moderna and Spark Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Orphan Technologies was founded in 2010 and is based in Lexington, United States. Focus is placed on biotechnology for rare diseases, with operations centered on enzyme replacement therapies. The lead candidate, OT-58, consists of a recombinant enzyme intended for homocystinuria treatment and remains in pre-clinical trials. Development efforts target unmet needs in metabolic disorders through targeted enzymatic interventions.

  • Headquarters Lexington, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website orphantechnologies.com
  • Acquired by Retrophin (Oct 2020)
Operational Areas
Key Metrics

Investors in Orphan Technologies

Orphan Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Retrophin.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Drugs are developed for debilitating and life-threatening diseases.
2011retrophin.comSan Diego, United States
Premium access

Investor details for Orphan Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Orphan Technologies

2 dated milestones of Orphan Technologies across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Orphan Technologies is founded.
  2. Exit Acquired by Retrophin.

Competitors of Orphan Technologies

Orphan Technologies has 3 listed competitors in our database, 3 of them funded. They include BridgeBio, Moderna and Spark Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bridgebio.com2015Palo Alto, United States$434.2M
Therapeutics for genetic diseases are developed through targeted interventions.
modernatx.com2010Cambridge, United States$2.78B1,312
mRNA-based therapeutics for diseases including cancer and infections are developed.
sparktx.com2013Philadelphia, United States$82.8M822
Gene therapies for rare diseases including retinal dystrophies are developed.
Premium access

Detailed competitors of Orphan Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Rare Diseases

3 companies that operate in the same segment as Orphan Technologies (Rare Diseases) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Orphan Technologies

Premium access

Complete news archive for Orphan Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Orphan Technologies

Orphan Technologies was founded in 2010.

Orphan Technologies is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Orphan Technologies was founded in 2010 and is based in Lexington, United States. Focus is placed on biotechnology for rare diseases, with operations centered on enzyme replacement therapies. The lead candidate, OT-58, consists of a recombinant enzyme intended for homocystinuria treatment and remains in pre-clinical trials. Development efforts target unmet needs in metabolic disorders through targeted enzymatic interventions.

Orphan Technologies's top competitors include Moderna, Spark Therapeutics and BridgeBio.

Orphan Technologies has 1 investor. Key investors include Retrophin.

Yes. Orphan Technologies was acquired by Retrophin in October 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available